SCHEMBL1268486

SCHEMBL1268486

N=C(N)NS(=O)(=O)c1ccccc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.51
FLT1 P17948 1/20 0.51
FLT4 P35916 1/20 0.51
KDR P35968 1/20 0.51
SLC1A3 P43003 1/20 0.48
SLC1A2 P43004 1/20 0.48
SLC1A1 P43005 1/20 0.48
ALDH1A1 P00352 2/20 0.46
GAA P10253 1/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CA12 O43570 3/20 0.46
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CA9 Q16790 3/20 0.46
PGR P06401 1/20 0.43
PKM P14618 1/20 0.42
EDNRA P25101 1/20 0.40
SLC22A12 Q96S37 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL28282467 0.92 POLB (0.49) POLBFLT1FLT4KDRSLC1A3
SCHEMBL9846425 0.85 POLB (0.54) POLBFLT1FLT4KDRSLC1A3
SCHEMBL29543742 0.84 POLB (0.56) POLBFLT1FLT4KDRSLC1A3
SCHEMBL2351670 0.84 POLB (0.56) POLBFLT1FLT4KDRSLC1A3
SCHEMBL20528790 0.80 CA9 (0.50) GAACA12CA1CA2CA9
SCHEMBL1269864 0.79 FLT1 (0.49) FLT1FLT4KDRTSHREDNRA
SCHEMBL27567092 0.79 CA1 (0.50) POLBSLC1A3SLC1A2SLC1A1ALDH1A1
SCHEMBL10784100 0.78 POLB (0.58) POLBFLT1FLT4KDRSLC1A3
SCHEMBL3954909 0.78 POLB (0.58) POLBFLT1FLT4KDRSLC1A3
SCHEMBL8560217 0.77 CSNK1A1 (0.41) ALDH1A1L3MBTL1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0302378-A2 Sulphonylaminoguanidino azines BAYER AG (DE) 1989-02-08 EP claimed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 US disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 EP disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 EP disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 US disclosed
US-20060084802-A1 Bisaryl-sulfonamides AMGEN INC. 2006-04-20 US disclosed
EP-0343462-A1 Aminoguanidino azines BAYER AG (DE) 1989-11-29 EP disclosed
EP-0302378-A2 Sulphonylaminoguanidino azines BAYER AG (DE) 1989-02-08 EP disclosed
EP-0173315-A1 Oxyguanidine derivatives BAYER AG (DE) 1986-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221584-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG POLB 1629/4885FLT1 1549/4885FLT4 917/4885
US-20060084802-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG POLB 1629/4885FLT1 1549/4885FLT4 917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.